Strata Critical Medical (SRTA) Profit After Tax (2019 - 2026)

Strata Critical Medical (SRTA) has reported Profit After Tax for 8 consecutive years, with $2.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Profit After Tax rose 161.67% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $47.0 million (up 404.76% YoY), while the FY2025 annual figure was $41.3 million, up 355.84% from the prior year.
• Profit After Tax climbed to $2.2 million in Q1 2026 per SRTA's latest filing, from -$8.8 million in the prior quarter.
• Across five years, Profit After Tax topped out at $57.4 million in Q3 2025 and bottomed at -$33.9 million in Q4 2023.
• Historically, Profit After Tax has averaged -$3.7 million across 5 years, with a median of -$4.0 million in 2024.
• Annual changes were most pronounced in 2024 — Profit After Tax plunged 776.12% — and 2025, when it jumped 3038.38%.
• Strata Critical Medical's Profit After Tax stood at -$27.3 million in 2022, then slipped by 24.51% to -$33.9 million in 2023, then surged by 103.99% to $1.4 million in 2024, then tumbled by 752.85% to -$8.8 million in 2025, then soared by 124.39% to $2.2 million in 2026.
• Business Quant data shows SRTA's Profit After Tax at $2.2 million in Q1 2026, -$8.8 million in Q4 2025, and $57.4 million in Q3 2025.